[{"id":"40c12235-7a66-4e0e-89ba-dbffecad221c","acronym":"","url":"https://clinicaltrials.gov/study/NCT05351788","created_at":"2022-04-28T16:57:05.872Z","updated_at":"2024-07-02T16:35:26.230Z","phase":"Phase 2","brief_title":"SKB264 Combinatiton Therapy in Patients With Advanced or Metastatic Non-small Cell Lung Cancer.","source_id_and_acronym":"NCT05351788","lead_sponsor":"Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.","biomarkers":" ALK","pipe":" | ","alterations":" EGFR mutation • EGFR wild-type • ALK fusion • ALK negative","tags":["ALK"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EGFR mutation • EGFR wild-type • ALK fusion • ALK negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cisplatin • carboplatin • Jiataile (sacituzumab tirumotecan) • Cotelet (tagitanlimab)"],"overall_status":"Recruiting","enrollment":" Enrollment 110","initiation":"Initiation: 05/20/2022","start_date":" 05/20/2022","primary_txt":" Primary completion: 08/01/2024","primary_completion_date":" 08/01/2024","study_txt":" Completion: 04/01/2026","study_completion_date":" 04/01/2026","last_update_posted":"2023-12-14"},{"id":"4aa2437c-ec63-45ac-b45d-743638a6c18c","acronym":"","url":"https://clinicaltrials.gov/study/NCT05445908","created_at":"2023-10-24T00:13:52.884Z","updated_at":"2024-07-02T16:35:32.398Z","phase":"Phase 2","brief_title":"SKB264 +/- KL-A167 in Recurrent or Metastatic HER2-negative Breast Cancer","source_id_and_acronym":"NCT05445908","lead_sponsor":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.","biomarkers":" HER-2","pipe":" | ","alterations":" HER-2 negative","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Jiataile (sacituzumab tirumotecan) • Cotelet (tagitanlimab)"],"overall_status":"Recruiting","enrollment":" Enrollment 175","initiation":"Initiation: 08/17/2022","start_date":" 08/17/2022","primary_txt":" Primary completion: 04/01/2025","primary_completion_date":" 04/01/2025","study_txt":" Completion: 07/01/2025","study_completion_date":" 07/01/2025","last_update_posted":"2023-10-20"}]